Gelteq Ltd (GELS) stock
GELSNasdaqPharmaceutical PreparationsFiscal year ends June 30
$0.38−0.00 (-0.13%)
Close on Nov 13, 2026Market cap $4.07MP/E –Yield –
Gelteq ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
For fiscal 2025 it was -A$4.27M.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | -A$4.27M | – |
| FY2024 | Jun 30, 2024 | -A$1.73M | – |
| FY2023 | Jun 30, 2023 | -A$1.88M | – |
See a number that looks wrong?